Sleep Aid Recommendation for Quality of Sleep
For an otherwise healthy adult seeking to improve sleep quality, melatonin sustained-release 2 mg taken at night is the recommended first-line option, offering significant improvements in both objective and subjective sleep measures with minimal side effects.
Primary Recommendation: Melatonin
The most recent high-quality evidence from 2026 demonstrates that sustained-release melatonin 2 mg produces clinically meaningful improvements in sleep quality 1. This formulation showed:
- Significant improvement in sleep efficiency (3.49% increase vs. 6.30% decrease with placebo, p=0.001)
- Increased total sleep time (23.83 minutes gained vs. 39.25 minutes lost with placebo, p=0.001)
- Reduced sleep onset latency (10.28 minutes faster vs. 16.70 minutes slower with placebo, p=0.031)
- Large treatment effect (Cohen's d = 0.9) for sleep efficiency improvement
- Sustained benefits with improvements in subjective sleep quality (PSQI scores) evident from day 7 and continuing through day 28
The safety profile was excellent, with only mild and transient adverse events reported 1.
Supporting Evidence and Context
Why Melatonin Over Prescription Options
While the American College of Physicians guideline identifies eszopiclone, zolpidem, and suvorexant as effective for insomnia disorder, these medications come with important caveats 2:
- Small absolute effect sizes despite statistical significance
- Serious safety concerns including cognitive and behavioral changes, driving impairment, and observational data linking hypnotics to increased risk of dementia, fractures, and major injury
- FDA warnings about dose reduction needs, particularly in women and older adults
- Limited long-term efficacy data with most trials being small and short-term
For an otherwise healthy adult seeking sleep quality improvement (rather than treating diagnosed insomnia disorder), the risk-benefit profile of prescription hypnotics is unfavorable.
Additional Evidence for Melatonin
Multiple systematic reviews support melatonin's efficacy:
- A 2022 meta-analysis confirmed melatonin significantly improves subjective sleep quality (MD -1.21,95% CI -2.17 to -0.24) 3
- A 2025 scoping review identified melatonin and valerian as having "substantial evidence to demonstrate their effectiveness and safety" among over-the-counter products 4
Alternative Considerations
If Melatonin Is Insufficient
Amino acids (such as L-theanine) showed significant sleep quality improvement in meta-analysis (MD -1.27,95% CI -2.35 to -0.20) 3, though evidence is less robust than for melatonin.
Magnesium supplementation has promising but less conclusive evidence and may be considered as an adjunct 5, 3.
Probiotics as Emerging Option
Recent 2026 evidence suggests probiotic supplementation modestly improves sleep quality (PSQI MD -0.59, p<0.001) 6, though this represents a newer area requiring further validation before routine recommendation.
Important Caveats
- Dosing matters: The sustained-release formulation at 2 mg appears optimal. Higher doses (5 mg commonly used) may not provide additional benefit and could increase side effects 7
- Timing: Take 30-60 minutes before desired sleep time
- Duration: Benefits accumulate over time, with maximal effects by 28 days 1
- Common side effects: Drowsiness (28.8%) and headache (25.1%) are most frequently reported but typically mild 7
- Not for insomnia disorder: If symptoms meet criteria for insomnia disorder (chronic, persistent, ≥3 nights/week for ≥3 months with daytime dysfunction), formal evaluation and potentially prescription therapy may be warranted 2
Why This Recommendation
This recommendation prioritizes quality of life and safety (morbidity/mortality considerations) by selecting an intervention with:
- Strong objective evidence (polysomnography-confirmed improvements)
- Excellent safety profile without serious adverse events
- Most recent, high-quality trial data (2026)
- Practical applicability to healthy adults seeking sleep quality improvement
- Avoidance of prescription hypnotics' serious long-term risks in a population not requiring them